Application of Tetrabenazine_Kain Industrial Additive

Background and overview[1][2] Tetrabenazine was first marketed in Switzerland and was initially used for the treatment of schizophrenia. In August 2008, it was approved for marketing by the U.S. Food and Drug Administration (FDA) with fast-track approval status, becoming the first and only drug to treat Huntington’s disease (HD) in the United States. HD is…